Background A recent meta-analysis suggested that anal intraepithelial neoplasia and invasive anal cancer are more prevalent among black men having sex with men (MSM). Methods We conducted a retrospective cohort of HIVinfected adult patients under care between 2001 and 2012. Disparities in clinical evolution of anal intraepithelial neoplasia to high-grade squamous intraepithelial lesion (HSIL) and invasive anal cancer were evaluated in a three-state Markov model adjusted for cytology misclassification. We studied sociodemographic covariate effects for each state transition using multivariable models controlling for antiretroviral therapy and infrared coagulation treatment of HSIL. Results Among 2804 patients with a median age of 40 years, 78% were MSM and 38% non-white. There were no disparities in HSIL prevalence (14%) by age, sex, race, or risk group. After 4.0 years of follow-up, 23 patients developed invasive anal cancer. Females and black patients had lower transition rates from <HSIL→HSIL (HR = 0.35 and HR = 0.55, respectively); those with age >40 had lower rates of both <HSIL→HSIL progression (HR = 0.64) and HSIL→ <HSIL regression (HR = 0.56); and MSM had higher rates of progression from <HSIL→HSIL (HR = 3.30). Controlling for antiretroviral therapy and infrared coagulation (IRC) treatment as time-updated covariates, the univariable effects of sex, black race, and HIV risk factor remained significant.
Introduction
Chronic immunosuppression induced by human immune deficiency virus (HIV) facilitates the persistence of human papillomavirus (HPV) [1] . Analogous to cervical cancer, chronic HPV infection induces sequential changes in the anal canal mucosa called anal intraepithelial neoplasia (AIN) of which high-grade squamous intraepithelial lesion (HSIL) is the immediate precursor of invasive anal cancer (IAC) [2] . In the USA, the incident rate is highest among black men who have sex with men (MSM) [3] . Black MSM disproportionally have higher rates of lack of engagement in care, uncontrolled HIV infection, and resulting immunosuppression [4] . A recent systematic review suggested that anal neoplasia outcomes including AIN and IAC may be more prevalent among black MSM than other groups [5] .
We previously developed a multistate Markov model of AIN natural history. In this model, HSIL is assumed to be the immediate precursor lesion to invasive anal cancer, from which both progression to IAC and regression to less than HSIL (<HSIL) may occur. IAC is considered an absorbing state from which regression does not occur in the absence of definitive treatment. We demonstrated favorable effects for antiretroviral therapy use, higher CD4 cell counts, HIV viral load suppression, and infrared coagulation (IRC) ablation on selected AIN transition rates [6] .
The aim of this study was to evaluate potential sociodemographic disparities in the baseline prevalence and clinical evolution of AIN in the University of California, San Diego Owen Clinic anal neoplasia cohort.
Methods
We assembled a clinical care cytology-based retrospective cohort including the anal cytology test results and IAC outcomes of all HIV-infected adults under care at the UCSD Owen Clinic between 2001 and 2012. Eligibility criteria, screening program characteristics, and study measure definitions were as previously reported [6] . In short, every adult HIV-infected patient attending care in our clinic underwent a baseline anal cytology test and digital rectal exam (DRE) at the time of clinic enrollment and yearly thereafter as part of their routine HIV care. Patients with any abnormal anal cytology results or anal symptoms were referred for a diagnostic high-resolution anoscopy (HRA) procedure. Preferential HRA referral was for patients with HSIL cytology results or abnormal DRE due to the limited number of providers trained in performing HRA. Entry was defined as the date of the first screening anal cytology obtained at clinic entry (for those who entered care after the inauguration of the screening program in 2001) or as the date of the first anal cytology (for those already under care when the screening program was started). A three-state Markov model was estimated for all patients (inception cohort) according to cytology results: <HSIL↔HSIL→IAC. Cytology states were adjusted for misclassification using within-cohort estimates of sensitivity (0.66) and specificity (0.90), with concurrent HRA-directed biopsy as the reference standard [7] . State transition rates (per person-year) and prognostic covariate hazard ratios were estimated using the R package msm adjusted for antiretroviral therapy and timeupdated IRC treatment [8] . The study was conducted according to the principles expressed in the Declaration of Helsinki. The study was approved by the University of California, San Diego Human Research Protection Program (Project 071931). Table 1 presents the main sociodemographic, HIV, and AINrelated characteristics of the overall inception cohort and stratified according to the race-ethnicity category. Overall, patients had a median age of 40 years old and were followed for a median time of 4 years. Nine out of ten patients were male; 80% of them were MSM. According to race, 38% were non-white including 13% who were black. Most patients (75%) were taking antiretroviral therapy, and 50% had controlled viremia (<400 copies/ml). At baseline, there was no difference according to race in the prevalence of antiretroviral therapy use, the proportion of HIV patients with viral suppression, or prevalence of HSIL anal cytology (~14%). There was a higher proportion of females (25%) among black patients than in other groups. Hispanic patients were younger and presented with lower CD4 cell counts (<350 cells/mm 3 ) than other groups at study entry. The median follow-up time of black, white, and Hispanic patients was similar and ranged from 49 to 52 months but considerably higher than patients in the other/unknown racial category (35 months). During the follow-up period, black patients had a lower median number of collected sequential anal cytology tests than other groups (3 vs. 4). White patients had a higher proportion of ever developing an HSIL cytology (41%) in comparison to Hispanics (38%) and blacks (33%). There were no racial differences in the proportion of patients undergoing IRC ablation of HSIL lesions. A total of 23 patients developed IAC with similar distribution in the proportion of IAC cases among all race categories. Table 2 shows covariate effects on different transition states of anal dysplasia according to Markov model estimates. In unadjusted analysis of progression to HSIL, female sex, age ≥40.5 years, and black race were associated with significantly lower transition rates (than their comparators) from <HSIL to HSIL with hazard ratios (HR) of 0.35, 0.64, and 0.55, respectively. In contrast, MSM HIV transmission risk factor was associated with a substantially increased rate of transition from <HSIL to HSIL (HR 3.30). With regard to regression of HSIL, those with age above 40.5 years had a lower rate of HSIL to <HSIL regression (HR = 0.56) while MSM had a higher rate of HSIL regression (HR = 1.90). After controlling for antiretroviral therapy use and timed-updated IRC treatment, all observed unadjusted effects remained significant with the exception of the effect of higher age on the transition from <HSIL to HSIL.
Results

Discussion
This study found no differences in the baseline prevalence of HSIL, the immediate precursor of IAC, nor in the proportion of observed IAC cases according to race category after a median of 4 years of follow-up. In addition, race was not associated with a more rapid progression rate between the AIN states in unadjusted and adjusted Markov models.
The presented results contrast with the findings of a recent meta-analysis, which observed that anal dysplasia was more frequent in black MSM than in non-black MSM (55 vs. 44%), although the reported difference was not statistically significant [5] . The meta-analysis also suggested that rates of anal cancer were higher in blacks than in whites, albeit there were considerable referral bias and heterogeneity in outcomes of included studies that made interpretation of the metaanalysis results difficult [5] . We previously showed that including patients with only higher severity of disease overestimates outcomes in anal neoplasia [9] . The present study uses an inception cohort, where a group of individuals was identified and assembled for subsequent study at an early and uniform point in the course of the specified health condition. The study population at the UCSD Owen Clinic mirrors the HIVepidemic distribution in San Diego County. Overall, 5.6% of the population are black, but HIV prevalence in the black community is approximately 12% in San Diego County [10] . Social disparities do exist in HIV health care [11] . Lack of engagement in care is a prevalent problem among minorities such as the black community. This results in a higher proportion of patients with uncontrolled HIV infections and transmission risk [11] . Noteworthy, we observed that in our cohort, black patients had a lower median number of serial anal cytology tests than other groups. We speculate that this is due to higher rates of missed appointments rather than differences in provider's treatments. This speculation is indirectly supported by the similar proportion of patients receiving antiretroviral therapy regardless of race group in our clinic. Similarly, there were no differences in the proportion of IRC treatments according to race groups, once patients were diagnosed with anal HSIL lesions. Nevertheless, despite the aforementioned difference, the relative homogenous follow-up time among blacks, Hispanics, and whites (4 years) and sample size provided us robust estimates suggesting that AIN may progress to HSIL at a slower rate in black than in white patients. This observation should not deter ongoing efforts to improve access and engagement in care among minorities including blacks. Even in the absence of a worsening effect of black race on the clinical evolution of AIN, lack of engagement in care could potentially influence delay in care, diagnosis, and worst anal neoplasia outcomes.
Our study has important limitations. (1) There is possible residual state misclassification after correcting for the fallibility of cytology using HRA-directed biopsy as reference standard HRA-directed biopsy. However, an HRA-directed biopsy is itself a fallible reference standard. (2) The <HSIL state is a heterogeneous state including some HPV-uninfected patients. Nonetheless, similar HIV-infected cohorts have demonstrated high incidence and persistence of oncogenic HPV. Gruger et al. have demonstrated in a simulation study that when the interval between successive tests is chosen on the basis of the current observation (as would be the case in severity-based examination schedules), little bias is anticipated. However, if the examination interval is determined by patient self-selection, considerable bias is likely [12] . (5) The observed associations for sex, age, MSM, and race on selected AIN state transitions may reflect underlying biological differences but may also be attributable to non-biological factors or to unmeasured confounding. Replicate analysis in other cohorts is needed.
In conclusion, unlike previous reports, black race was not associated with either prevalent AIN nor with worsening postbaseline transition of AIN states.
